SynthesisPeerJ2022

Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis.

Jia Jie Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.